We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002261:SZSETalkweb Information System Co.,Ltd. Analysis

Data as of 2026-03-17 - not real-time

CN¥37.17

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Talkweb’s share price of 37.17 CNY sits above its 20‑day (≈36.27), 50‑day (≈34.47) and 200‑day (≈33.30) moving averages, and the technical trend is flagged as bullish with rising volume, suggesting short‑term momentum. However, the fundamentals tell a different story: revenue has slumped by roughly 36.5% year‑over‑year, profit margin is negative (-0.2%), and the forward earnings‑per‑share estimate of 0.19 translates into an eye‑watering forward P/E of about 195×, far above the industry average of 34.5×. The discounted‑cash‑flow model caps fair value near 13.96 CNY, indicating the stock is trading at a steep premium relative to intrinsic estimates, while the price‑to‑book ratio of 18× further underscores overvaluation.
Risk considerations are amplified by a 30‑day volatility of over 60% and a modest beta of 0.16, reflecting high price swings but low market‑wide correlation. The technology‑services sector in China faces medium to high regulatory scrutiny, and the company’s negative earnings, high debt‑to‑equity ratio, and lack of dividend make cash‑flow sustainability a concern. Given the confluence of strong technical signals but weak financial health and a substantial valuation gap, investors should approach the stock with caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price approaching resistance while MACD turns bearish
  • Extreme overvaluation relative to DCF fair value
  • Negative profit margin and ongoing revenue decline

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained high forward P/E versus industry peers
  • Elevated volatility and regulatory headwinds in Chinese tech
  • Strong cash position but leverage remains high

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside from digital‑platform and AI initiatives
  • Need for an earnings turnaround to justify current price
  • Long‑run exposure to sector‑specific policy risk

Key Metrics & Analysis

Financial Health

Revenue Growth-36.50%
Profit Margin-0.21%
P/E Ratio195.6
ROE-0.86%
ROA-0.50%
Debt/Equity15.09
P/B Ratio18.0
Op. Cash FlowCN¥1.4B
Free Cash FlowCN¥1.2B
Industry P/E34.5

Technical Analysis

TrendBullish
RSI53.2
SupportCN¥31.30
ResistanceCN¥44.06
MA 20CN¥36.27
MA 50CN¥34.47
MA 200CN¥33.30
MACDBearish
VolumeIncreasing
Fear & Greed Index81.91

Valuation

Fair ValueCN¥13.96
GradeOvervalued
TypeValue

Risk Assessment

Beta0.16
Volatility62.62%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.